A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients
- 9 September 1999
- journal article
- clinical trial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 341 (11), 793-800
- https://doi.org/10.1056/nejm199909093411103
Abstract
The efficacy and safety of thromboprophylaxis in patients with acute medical illnesses who may be at risk for venous thromboembolism have not been determined in adequately designed trials.Keywords
This publication has 32 references indexed in Scilit:
- Randomised, controlled trial of low-dose heparin for prevention of fatal pulmonary embolism in patients with infectious diseasesThe Lancet, 1996
- Low molecular weight heparin in prevention of perioperative thrombosis.BMJ, 1992
- Risk of and prophylaxis for venous thromboembolism in hospital patients. Thromboembolic Risk Factors (THRIFT) Consensus Group.BMJ, 1992
- The prevalence of risk factors for venous thromboembolism among hospital patientsArchives of Internal Medicine, 1992
- Incidence of venous thromboembolism verified by necropsy over 30 years.BMJ, 1991
- Prevalence and Prevention of Deep Venous Thrombosis of the Lower Extremities in High-Risk Pulmonary PatientsAngiology, 1988
- Reduction in Fatal Pulmonary Embolism and Venous Thrombosis by Perioperative Administration of Subcutaneous HeparinNew England Journal of Medicine, 1988
- Low molecular weight heparin compared with unfractionated heparin in prevention of postoperative thrombosisBritish Journal of Surgery, 1988
- A cost-effectiveness analysis of prophylaxis against deep-vein thrombosis in major orthopedic surgeryPublished by American Medical Association (AMA) ,1987
- High risk of the critically ill for venous thromboembolismCritical Care Medicine, 1982